GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » EV-to-EBIT

Pediatrix Medical Group (Pediatrix Medical Group) EV-to-EBIT

: -204.12 (As of Today)
View and export this data going back to 1959. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pediatrix Medical Group's Enterprise Value is $1,283 Mil. Pediatrix Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6 Mil. Therefore, Pediatrix Medical Group's EV-to-EBIT for today is -204.12.

The historical rank and industry rank for Pediatrix Medical Group's EV-to-EBIT or its related term are showing as below:

MD' s EV-to-EBIT Range Over the Past 10 Years
Min: -214.93   Med: 13.78   Max: 35.66
Current: -204.12

During the past 13 years, the highest EV-to-EBIT of Pediatrix Medical Group was 35.66. The lowest was -214.93. And the median was 13.78.

MD's EV-to-EBIT is ranked worse than
100% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 18.57 vs MD: -204.12

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pediatrix Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was $1,305 Mil. Pediatrix Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-6 Mil. Pediatrix Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.48%.


Pediatrix Medical Group EV-to-EBIT Historical Data

The historical data trend for Pediatrix Medical Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.24 22.75 14.37 15.25 -207.71

Pediatrix Medical Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.25 11.67 10.95 10.29 -207.71

Competitive Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pediatrix Medical Group EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's EV-to-EBIT falls into.



Pediatrix Medical Group EV-to-EBIT Calculation

Pediatrix Medical Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1282.660/-6.284
=-204.12

Pediatrix Medical Group's current Enterprise Value is $1,283 Mil.
Pediatrix Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pediatrix Medical Group  (NYSE:MD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pediatrix Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-6.284/1305.2724
=-0.48 %

Pediatrix Medical Group's Enterprise Value for the quarter that ended in Dec. 2023 was $1,305 Mil.
Pediatrix Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pediatrix Medical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Traded in Other Exchanges
Address
1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.
Executives
James D Swift officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E officer: EVP Chief ERM/Legal Ops Off 1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan director, officer: Chief Executive Officer 7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis director 11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young director C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood officer: EVP, Natl & Market Operations 1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert officer: EVP, Chief Operating Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky director 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel director, officer: PRES. & CHIEF EXEC. OFFICER 1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia officer: Principal Accounting Officer 1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson officer: Pres., PDX & OBX Medical Group C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards officer: EVP, Chief Financial Officer 7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano officer: Sr.VP,General Counsel & Secy. 1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos officer: EVP Chf Strategy & Growth Offi MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323